Alfasigma's $800 million buyout of Intercept Pharma two years ago is starting to look like a poor bet, as its only approved product, Ocaliva, is pulled off the market in the US and all trials of the ...

Bulgaria is drafting new legislation that will allow it to seize control of an important oil refinery belonging to Russia's sanctioned oil giant Lukoil. The Burgas refinery is the only one of its kind ...